Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Bernstein

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Clinical and Experimental Immunology|April 23, 2014
Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trialA Malbrán, M Riedl, B Ritchie, et al.
The Journal of Allergy and Clinical Immunology|December 16, 1998
Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstructionR A Nathan, J A Bernstein, L Bielory, et al.
The British Journal of Dermatology|September 21, 2020
The global burden of chronic urticaria for the patient and societyM Gonçalo, A Gimenéz-Arnau, M Al-Ahmad, et al.
Allergy|March 25, 2024
Response to Correspondence to "Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy"P J de Kam, S Zielen, J A Bernstein, et al.
Allergy|June 27, 2023
Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergyP J de Kam, S Zielen, J A Bernstein, et al.
Allergy|April 25, 2018
Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 studyM A Riedl, E Aygören-Pürsün, J Baker, et al.
Pulmonary Pharmacology & Therapeutics|November 21, 2024
Triple inhaled therapy in asthma: Beliefs, behaviours and doubtsD Bagnasco, I Ansotegui, I Baiardini, et al.
Clinical Genetics|October 27, 2015
Clinical reappraisal of SHORT syndrome with PIK3R1 mutations: toward recommendation for molecular testing and managementM Avila, D A Dyment, J V Sagen, et al.
Allergy|January 17, 2018
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticariaT Zuberbier, W Aberer, R Asero, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Clinical and Experimental Immunology|April 23, 2014
Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trialA Malbrán, M Riedl, B Ritchie, et al.
The Journal of Allergy and Clinical Immunology|December 16, 1998
Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstructionR A Nathan, J A Bernstein, L Bielory, et al.
The British Journal of Dermatology|September 21, 2020
The global burden of chronic urticaria for the patient and societyM Gonçalo, A Gimenéz-Arnau, M Al-Ahmad, et al.
Allergy|March 25, 2024
Response to Correspondence to "Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy"P J de Kam, S Zielen, J A Bernstein, et al.
Allergy|June 27, 2023
Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergyP J de Kam, S Zielen, J A Bernstein, et al.
Allergy|April 25, 2018
Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 studyM A Riedl, E Aygören-Pürsün, J Baker, et al.
Pulmonary Pharmacology & Therapeutics|November 21, 2024
Triple inhaled therapy in asthma: Beliefs, behaviours and doubtsD Bagnasco, I Ansotegui, I Baiardini, et al.
Clinical Genetics|October 27, 2015
Clinical reappraisal of SHORT syndrome with PIK3R1 mutations: toward recommendation for molecular testing and managementM Avila, D A Dyment, J V Sagen, et al.
Allergy|January 17, 2018
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticariaT Zuberbier, W Aberer, R Asero, et al.
Pageof 6